We showed that SCARB1 for the risk of nephrosclerosis, PLA2G7 and, especially, PLA2G4A for the CV risk in these patients, are loci that harbor genetic variants whose identification could be of utility in the management of this CKD. Here, PLA2G4A is linked to nephrosclerosis.